Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Growth Metrics

BioCorRx (BICX) Other Non-Current Liabilities (2016 - 2024)

BioCorRx (BICX) has disclosed Other Non-Current Liabilities for 9 consecutive years, with $80190.0 as the latest value for Q2 2024.

Quarterly Other Non-Current Liabilities changed N/A to $80190.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $80190.0 through Jun 2024, changed N/A year-over-year, with the annual reading at $53460.0 for FY2023, N/A changed from the prior year.
Other Non-Current Liabilities hit $80190.0 in Q2 2024 for BioCorRx, roughly flat from $80190.0 in the prior quarter.
In the past five years, Other Non-Current Liabilities ranged from a high of $80190.0 in Q1 2024 to a low of $53460.0 in Q4 2023.